Results
1 -
10 of
46O. M. Peeters, N. M. Blaton and C. J. De Ranter.
(+)-(S)-1-{4-[(2-Benzothiazolyl)(methyl)amino]piperidyl}-3-(3,4-difluorophenoxy)-2-propanol (Lubeluzole), Acta Cryst. (1995). C51, 2129-2132Â Â Â Â Q-type Ca2+ channels are located closer to secretory sites than L-type channels: functional evidence in chromaffin cells, Pfl??gers Archiv Neuroprotective Drugs, Neuroanesthesia and Cerebrospinal Protection New opportunities for stroke prevention and therapeutics: a hope from anti-inflammatory drugs?, Inflammation and Stroke Cerebral Taurine Release Mechanisms In Vivo: Pharmacological Investigations in Rats Using Microdialysis for Proof of Principle, Neurochemical Research Extracellular Taurine as a Parameter to Monitor Cerebral Insults ?On-Line?, Taurine 4 Headline news of 1997 ? part 2, Inpharma Weekly Methodological quality of animal studies on neuroprotection in focal cerebral ischaemia, Journal of Neurology Combination of Thrombolytic Therapy With Neuroprotectants, Thrombolytic Therapy for Acute Stroke